Publication | Closed Access
Prognostic Significance of Lymphocyte Counts in Colon Cancer Patients Treated with FOLFOX Chemotherapy
32
Citations
22
References
2017
Year
Lymphocyte count during chemotherapy is a strong predictor of worse disease-free survival in colon cancer patients who have undergone FOLFOX adjuvant chemotherapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1